Praxis Precision Medicines, Inc. (PRAX)
USD 70.12
(-3.96%)
USD 70.12
(-3.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.44 Million | - | - | - | - | - |
| Cost of Revenue | 86.76 Million | 1.17 Million | 1.59 Million | 746 Thousand | 679 Thousand | 1000.00 |
| Gross Profit | -84.31 Million | -1.17 Million | -1.59 Million | -746 Thousand | -679 Thousand | -1000.00 |
| Operating Expenses | 128.82 Million | 214.98 Million | 167.33 Million | 61.96 Million | 35.78 Million | 22.71 Million |
| Selling, General and Administrative Expenses | 42.05 Million | 59.94 Million | 47.07 Million | 16.99 Million | 6.23 Million | 3.89 Million |
| Research and Development Expenses | 86.76 Million | 155.04 Million | 120.25 Million | 44.97 Million | 29.55 Million | 18.82 Million |
| Other Expenses | - | 957 Thousand | 271 Thousand | 140 Thousand | - | -3.64 Million |
| Cost and Expenses | 128.82 Million | 214.98 Million | 167.33 Million | 61.96 Million | 35.78 Million | 22.71 Million |
| Operating Income | -126.37 Million | -214.98 Million | -167.33 Million | -61.96 Million | -35.78 Million | -22.71 Million |
| Interest Expense | - | - | - | - | - | 127 Thousand |
| Income Tax Expense | - | -957 Thousand | -182 Thousand | -8000.00 | -84 Thousand | 133 Thousand |
| Earnings before Tax | -123.27 Million | -214.02 Million | -167.06 Million | -61.82 Million | -35.59 Million | -26.4 Million |
| Net Income | -123.27 Million | -213.07 Million | -166.87 Million | -61.82 Million | -35.51 Million | -26.53 Million |
| Earnings Per Share Basic | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| Earnings Per Share Diluted | -18.69 | -69.33 | -58.96 | -103.61 | -348.24 | -306.73 |
| Weighted Average Shares Outstanding | 6.59 Million | 3.07 Million | 2.83 Million | 596.67 Thousand | 101.97 Thousand | 86.5 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 6.59 Million | 3.07 Million | 2.83 Million | 596.67 Thousand | 101.97 Thousand | 86.5 Thousand |
| Gross Margin | -34.46 | - | - | - | - | - |
| EBIT Margin | -51.47 | - | - | - | - | - |
| Profit Margin | -50.38 | - | - | - | - | - |
| EBITDA | -125.94 Million | -212.85 Million | -165.46 Million | -61.08 Million | -34.91 Million | -26.27 Million |
| Earnings Before Tax Margin | -51.64 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 357 Thousand | 431 Thousand | 2.44 Million | 515 Thousand | 468 Thousand | 781 Thousand |
| Cost of Revenue | 107 Thousand | 112 Thousand | 432 Thousand | 111 Thousand | 321 Thousand | 312 Thousand |
| Gross Profit | 250 Thousand | 319 Thousand | 2.01 Million | 404 Thousand | 147 Thousand | 469 Thousand |
| Operating Expenses | 37.84 Million | 42.31 Million | 128.82 Million | 28.32 Million | 25.98 Million | 35.74 Million |
| Selling, General and Administrative Expenses | 10.58 Million | 15.33 Million | - | 9.93 Million | 8.72 Million | 10.12 Million |
| Research and Development Expenses | 27.26 Million | 26.98 Million | - | 18.38 Million | 17.26 Million | 25.61 Million |
| Other Expenses | 4.81 Million | 2.33 Million | 3.09 Million | 928 Thousand | 884 Thousand | 648 Thousand |
| Cost and Expenses | 37.84 Million | 42.31 Million | 128.82 Million | 28.32 Million | 25.98 Million | 35.74 Million |
| Operating Income | -37.48 Million | -41.88 Million | -126.37 Million | -27.8 Million | -25.51 Million | -34.96 Million |
| Interest Expense | - | - | - | 106 Thousand | - | - |
| Income Tax Expense | -107 Thousand | -112 Thousand | 264.1 Thousand | 745 Thousand | -109 Thousand | -16.08 Thousand |
| Earnings before Tax | -32.67 Million | -39.55 Million | -123.27 Million | -26.87 Million | -24.63 Million | -34.31 Million |
| Net Income | -32.67 Million | -39.55 Million | -123.27 Million | -26.87 Million | -24.63 Million | -34.31 Million |
| Earnings Per Share Basic | -1.74 | -2.84 | - | -2.97 | -2.72 | -7.38 |
| Earnings Per Share Diluted | -1.74 | -2.84 | - | -2.97 | -2.72 | -7.38 |
| Weighted Average Shares Outstanding | 18.82 Million | 13.9 Million | 6.59 Million | 9.06 Million | 9.03 Million | 4.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.82 Million | 13.9 Million | 6.59 Million | 9.06 Million | 9.03 Million | 4.64 Million |
| Gross Margin | 0.70 | 0.74 | 0.82 | 0.78 | 0.31 | 0.60 |
| EBIT Margin | -105.01 | -97.18 | - | -53.78 | -54.52 | -44.63 |
| Profit Margin | -91.53 | -91.77 | -50.38 | -52.19 | -52.63 | -43.93 |
| EBITDA | -37.48 Million | -41.88 Million | - | -27.69 Million | -25.51 Million | -34.85 Million |
| Earnings Before Tax Margin | -105.01 | -97.18 | -51.64 | -53.99 | -54.52 | -44.76 |
PURVA
DGDCF
WSC
2321
LEN
HYBRIDFIN